Vertex Pharmaceuticals Inc. 8-K Filing Report: Key Insights and Developments
Based on the provided section of the financial report, here are the key details and insights extracted:
- Entity Information:
- Company Name: Vertex Pharmaceuticals Inc.
- CIK (Central Index Key): 0000875320
- State: Massachusetts (MA)
- Address: 50 Northern Avenue, Boston, MA 02210
- Contact Number: 617-341-6100
- Filing Information:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: May 14, 2025
- SEC File Number: 000-19319
- IRS Number: 04-3039129
- Stock Information:
- Security Type: Common Stock
- Par Value: $0.01 per share
- Ticker Symbol: VRTX
- Exchange: NASDAQ
- Reporting Period:
- Report Date: The report is dated May 14, 2025, indicating this is a current report.
Insights:
- Vertex Pharmaceuticals is actively reporting significant corporate events as indicated by the 8-K filing, which may suggest recent developments that could impact investors or stakeholders.
- The company is publicly traded on NASDAQ, and the common stock has a low par value, which is typical for many publicly traded companies.
- The provided contact information and corporate address can be useful for investors seeking further information or clarification about the company's activities or financial performance.
This information highlights Vertex Pharmaceuticals' compliance with SEC regulations and provides a snapshot of its corporate identity and recent activities.